The fund was located in North America if to be more exact in United States. Alexandria Venture appeared to be a CVC structure as part of the corporation. The leading representative office of defined VC is situated in the San Francisco.
The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. This Alexandria Venture works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2016. Despite it in 2019 the fund had an activity.
This organization was formed by Joel Marcus.
Among the most popular portfolio startups of the fund, we may highlight Relay Therapeutics, Vividion Therapeutics, Synthego. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Therapeutics.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Alexandria Venture, startups are often financed by Flagship Pioneering, ARCH Venture Partners, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Pfizer Venture Investments, Polaris Partners. In the next rounds fund is usually obtained by Polaris Partners, iSELECT FUND, Lundbeckfonden Ventures.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Radiant Biotherapeutics | $8M | 25 Apr 2023 | Toronto, Ontario, Canada | ||
Tiamat Sciences | $2M | 09 Mar 2023 | Berkeley, California, United States | ||
Kojin Therapeutics | $60M | 09 Jun 2021 | Cambridge, Massachusetts, United States | ||
TARA Biosystems | $10M | 23 Jun 2020 | New York, New York, United States | ||
Crop Enhancement | $8M | 14 Apr 2020 | San Jose, California, United States | ||
Triplet Therapeutics | $49M | 17 Dec 2019 | Cambridge, Massachusetts, United States | ||
Immunitas Therapeutics | $39M | 21 Nov 2019 | Cambridge, Massachusetts, United States | ||
Relay Therapeutics | $400M | 20 Dec 2018 | Cambridge, Massachusetts, United States | ||
Nohla Therapeutics | $11M | 12 Jul 2018 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Radiant Biotherapeutics | $8M | 25 Apr 2023 | Toronto, Ontario, Canada | ||
Tiamat Sciences | $2M | 09 Mar 2023 | Berkeley, California, United States | ||
Kojin Therapeutics | $60M | 09 Jun 2021 | Cambridge, Massachusetts, United States | ||
TARA Biosystems | $10M | 23 Jun 2020 | New York, New York, United States | ||
Crop Enhancement | $8M | 14 Apr 2020 | San Jose, California, United States | ||
Triplet Therapeutics | $49M | 17 Dec 2019 | Cambridge, Massachusetts, United States | ||
Immunitas Therapeutics | $39M | 21 Nov 2019 | Cambridge, Massachusetts, United States | ||
Relay Therapeutics | $400M | 20 Dec 2018 | Cambridge, Massachusetts, United States | ||
Nohla Therapeutics | $11M | 12 Jul 2018 | Seattle, Washington, United States |